PREPROCEDURAL HIGH-SENSITIVITY C-REACTIVE PROTEIN DECREASE DURING INTENSIVE ATORVASTATIN THERAPY: THE PRESUMABLE IMPACT ON ATHEROSCLEROSIS PROGRESSION AFTER CORONARY STENTING

A. M. Shchinova,G.V. Shlevkova,A. Filatova,A. V. Potekhina,A.K. Osokina,I. V. Romasov,E. A. Zharova,E.A. Noeva,A.N. Samko,Masenko Vp,T. I. Arefieva,S. I. Provatorov

PREPROCEDURAL HIGH-SENSITIVITY C-REACTIVE PROTEIN DECREASE DURING INTENSIVE ATORVASTATIN THERAPY: THE PRESUMABLE IMPACT ON ATHEROSCLEROSIS PROGRESSION AFTER CORONARY STENTING

2019

A. M. Shchinova
G.V. Shlevkova
A. Filatova
A. V. Potekhina
A.K. Osokina
I. V. Romasov
E. A. Zharova
E.A. Noeva
A.N. Samko
Masenko Vp
T. I. Arefieva
S. I. Provatorov

Objective:Proinflammatory status is the risk factor for coronary atherosclerosis progression after coronary stenting (CS). Intensive statin treatment is associated with high-sensitivity C-reactive protein (hsCRP) concentration decline. We aimed to evaluate prognostic significance of preprocedural hs

Keywords:

Endocrinology
C-reactive protein
Atorvastatin
Diabetes mellitus
Internal medicine
Medicine
Cardiology
coronary stenting
Proinflammatory cytokine
coronary atherosclerosis
Risk factor
statin treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations